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Background & objectives: Diverse mechanisms have been identified in enteric bacteria for their adaptation 
and survival against multiple classes of antimicrobial agents. Resistance of bacteria to the most effective 
fluoroquinolones have increasingly been reported in many countries. We have identified that most of 
the enterotoxigenic Escherichia coli (ETEC) were resistant to several antimicrobials in a diarrhoea 
outbreak at Ahmedabad during 2000. The present study was done to identify several genes responsible 
for antimicrobial resistance and mobile genetic elements in the ETEC strains.
Methods: Seventeen ETEC strains isolated from diarrhoeal patients were included in this study. The 
antimicrobial resistance was confirmed by conventional disc diffusion method. PCR and DNA sequencing 
were performed for the identification of mutation in the quinolone resistance-determining regions 
(QRDRs). Efflux pump was tested by inhibiting the proton-motive force. DNA hybridization assay was 
made for the detection of integrase genes and the resistance gene cassettes were identified by direct 
sequencing of the PCR amplicons.   
Results: Majority of the ETEC had GyrA mutations at codons 83 and 87 and in ParC at codon 80. Six 
strains had an additional mutation in ParC at codon 108 and two had at position 84. Plasmid-borne qnr 
gene alleles that encode quinolone resistance were not detected but the newly described aac(6’)-Ib-cr gene 
encoding a fluoroquinolne-modifying enzyme was detected in 64.7 per cent of the ETEC. Class 1 (intI1) 
and class 2 (intI2) integrons were detected in six (35.3%) and three (17.6%) strains, respectively. Four 
strains (23.5%) had both the classes of integrons. Sequence analysis revealed presence of dfrA17, aadA1, 
aadA5 in class 1, and dfrA1, sat1, aadA1 in class 2 integrons. In addition, the other resistance genes such 
as tet gene alleles (94.1%), catAI (70.6%), strA (58.8%), blaTEM-1 (35.2%), and aphA1-Ia (29.4%) were 
detected in most of the strains. 
Interpretation & conclusions: Innate gene mutations and acquisition of multidrug resistance genes 
through mobile genetic elements might have contributed to the emergence of multidrug resistance (MDR) 
in ETEC. This study reinforces the necessity of utilizing molecular techniques in the epidemiological 
studies to understand the nature of resistance responsible for antimicrobial resistance in different species 
of pathogenic bacteria.
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 Enterotoxigenic Escherichia coli (ETEC) is an 
important cause of diarrhoea due to their expression 
of either heat-labile (LT) or heat-stable (ST) or both 
the enterotoxins. In developing countries, ETEC is 
generally associated with sporadic infection especially 
among children and travelers1. The first outbreak of 
ETEC mediated diarrhoea in India was reported from 
Ahmedabad, Gujarat, during 2000 and majority of 
the strains expressed multidrug resistance2. In clinical 
practice, there is a great deal of speculation regarding 
therapeutic and subtherapeutic use of antimicrobials 
as it helps in accelerating the development and 
dissemination of antimicrobial-resistant bacterial 
pathogens1. 
 Quinolones and fluoroquinolones are the first-
line drugs for the treatment of diarrhoea for many 
years. However, several studies have documented the 
emergence and spread of fluoroquinolone resistant 
enteric pathogens in India3-6. Quinolone resistance 
mechanisms have been described and characterized 
in a variety of bacteria7. These have mostly been 
related to specific mutations that lead to amino acid 
alterations in the quinolone-resistance determining 
regions (QRDRs) within the subunits constituting 
topoisomerases II (GyrA and GyrB) and IV (ParC 
and ParE), which are involved in DNA replication, 
recombination, transcription and in the partitioning 
the replicated chromosome7. Most of the quinolone 
resistant clinical isolates of E. coli have mutations in 
the QRDRs of both the gyrA and the parC. In addition, 
a novel mechanism of plasmid-mediated quinolone 
resistance (PMQR) was reported that involves DNA 
gyrase protection by a protein from the pentapeptide 
repeat family called Qnr8. Qnr determinant confers 
resistance to nalidixic acid and increases the MICs 
of fluoroquinolones by 4-8 folds and supplements the 
resistance with other mechanisms8. Recent studies 
stress the importance of the PMQR among different 
pathogenic bacteria of clinical origin9,10. The qnr gene 
alleles were also detected in bacterial strains that express 
extended spectrum β-lactamase (ESBL). In addition, 
involvement of many efflux pump mechanisms and 
presence of a novel gene, aac(6’)-Ib-cr encoding a 
fluoroquinolne-modifying enzyme (aminoglycoside 
acetyltransferase) have been detected in many enteric 
pathogens11. 
 Mobile genetic elements such as integrons have 
been identified in many multidrug resistant bacteria 
that play an important role in the acquisition and 
dissemination of several antibiotic resistance genes12. 
To date, at least eight classes of integrons have been 
described and each class is distinguished by differences 
in the sequences of the integrase gene. Majority of 
integrons identified among clinical isolates belongs to 
class 1 type13. Class 2 integrons exists in the transposon 
Tn7 or its derivatives, and the 3′-CS contains five tns 
genes involved in the movement of the transposon14. 
More than 60 different antibiotic-resistance genes, 
covering most antimicrobials presently in use, have 
been characterized in cassette structures. In all the 
reported cases, the cassettes have been inserted in the 
same orientation and are usually transcribed from a 
promoter in the 5’-CS15. 
 In this study, 17 ETEC strains isolated from a 
diarrhoeal outbreak in Ahmedabad during 2000, were 
analysed for mutation in the QRDR of gyrA and parC 
genes, resistance gene cassettes in the integrons, 
fluoroquinolone efflux and other genes mediating 
resistance to different antimicrobials.
Material & Methods
Bacterial strains: Seventeen E. coli isolates obtained 
from patients from a diarrhoeal outbreak during 2000 
in Ahmedabad, Gujarat, were included in this study. 
The detailed description of the outbreak along with the 
phenotypic and genetic features of the ETEC strains 
were published elsewhere2. E. coli (J53), Klebsiella 
pneumonia (NK835), Morgonella morgonii (500914) 
and Shigella flexneri 3a (IDH6663), harbouring qnr 
gene alleles A, B, D and S, respectively were used 
as positive control in the PCR assay. The amplicons 
of these strains were confirmed by DNA sequencing. 
Vibrio cholerae O1 (SK-10) and E. coli strain carrying 
R483::Tn7 were used in the preparation of DNA probes 
that were the positive controls for the detection of intI1 
and intI2, respectively. E. coli strain DH5α or C600 
was used as negative control in all the PCR assays. The 
ATCC strains E. coli 25922 and Staphylococcus aureus 
25923 were used as quality control in the antimicrobial 
susceptibility assay.
Antimicrobial susceptibility test: The susceptibility of 
ETEC strains to different antimicrobials was performed 
by disk diffusion method using commercially available 
discs (Becton, Dickinson & Co, Sparks, MD, USA). 
Disc containing ampicillin (A, 10 µg), chloramphenicol 
(Ch, 30 µg), co-trimoxazole (Co, 25 µg), gentamicin 
(G, 10 µg), neomycin (Ne, 30 µg), tetracycline (T, 
30 µg), streptomycin (S, 10 µg), nalidixic acid (Na, 
30 µg), cephalothin (Ce, 30 µg), amikacin (Am, 30 
µg), ceftazidime (Cf 10 µg), kanamycin (K, 30 µg), 
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ceftriaxone (Ci, 30 µg), ciprofloxacin (Cx, 5 µg), 
norfloxacin (Nx, 10 µg), cefotaxime (Ct, 30 µg) and 
ceftazidime (Tz, 30 µg) were used. Susceptibility 
patterns were based on the recommendations of the 
Clinical Laboratory Standards Institute16. 
 The minimal inhibitory concentrations (MICs) of 
nalidixic acid, ciprofloxacin, norfloxacin, cefotaxime 
and ceftazidime were determined by E-test (AB Biodisk, 
Solna, Sweden) or agar dilution technique17 using 
Mueller-Hinton agar (Difco, USA) supplemented with 
appropriate concentration of antimicrobials (Nacalai 
Tesque, Kyoto, Japan). All the ETEC strains were also 
tested for ESBL-production by modified double-disk 
synergy test, phenotypic confirmatory disk diffusion 
test and E-test with Ct and Tz strips.
Polymerase chain reaction (PCR) assay: DNA templates 
were prepared from 200 µl of overnight culture of the 
test strains in Luria Bretani broth (LB, Difco, USA) by 
centrifugation using mircofuge tubes and resuspending 
the bacterial pellet to the initial volume with distilled 
water. The crude template DNA was prepared by 
boiling for 10 min and directly used in the PCR assay. 
The reactions were performed in a GeneAmp PCR 
system 9700 (Applied Biosystems, USA). The target 
genes, primer sequences, PCR conditions and amplified 
product sizes are given in Table I. The PCR products 
were analyzed after electrophoresis and staining with 
ethidium bromide.
Nucleotide sequencing: The PCR products were purified 
either directly or using gel extraction kits (Qiagen, 
Hilden, Germany). Sequencing of both the DNA strands 
was performed with the Big Dye Terminator Cycle 
Sequencing kit (Applied Biosystems) according to the 
manufacturers’ instructions. The DNA fragments were 
sequenced and analyzed using an automated sequencer 
(ABI PRISM 310 DNA, Applied Biosystems). The 
nucleotide and deduced protein sequences were 
analyzed with DNASIS (Hitachi, Yokohama, Japan) 
and DNASTAR (DNA Star Inc. Madison, USA) 
software. Nucleotide sequences were analyzed by 
searching the GenBank database of the National Center 
for Biotechnology Information via the BLAST network 
service (www.ncbi.nlm.nih.gov/blast). 
Fluoroquinolone accumulation assay: E. coli cells were 
grown to mid-log phase in LB (OD600 = 0.4), harvested, 
and suspended in 0.2 M morpholinepropanesulphonic 
acid-Tris buffer (pH 7.0) to an optical density at 600 
nm of 20 per ml. Cells were energized with 0.2 per 
cent glucose for 20 min. Fluoroquinolones were 
added at a concentration of 10 µg/ml. Aliquots of this 
mixture was harvested and suspended in 1 ml of 100 
mM glycine-HCl (pH 3.0) and shaken for 1 h at room 
temperature. The amount of released fluoroquinolone 
was determined spectroflurometrically with excitation 
at 277 nm and emission at 448 nm. Experiments were 
done in triplicate and included repeated measurements 
after carbonyl cyanide m-chlorophenylhydrazone 
(CCCP) was added to the assay mixture as an inhibitor 
of the proton-motive force at a final concentration of 
100 µM. 
DNA hybridization analysis: Locations of intI1 
and intI2 were identified by colony hybridization 
assay using Hybond+ nylon membranes (Amersham 
Biosciences Corp, Bucks, UK). DNA probes for intI1, 
intI2 and aac(6′)-1b-cr genes were prepared by PCR 
using primers described in Table I with V. cholerae 
(SK10), R483::Tn7 plasmid and ETEC strain AV195 as 
templates, respectively. The probe DNA (integron) was 
labelled by digoxigenin (DIG) labelling and detection 
kit (Roche Diagnostic GmbH, Manheim, Germany) 
and aac(6′)-1b-cr probe was labelled with alkaline 
phosphatase (GE Healthcare, Buckinghamshire. 
UK). The identities of the amplified products were 
confirmed by PCR direct sequencing. Plasmid and 
genomic DNA of the integron positive isolates were 
extracted following standard procedures. Genomic 
DNA was digested with EcoRI and EcoRV enzymes 
(Takara Suzo Co Ltd, Otsu, Japan). The plasmid and the 
digested genomic DNA were subjected to 0.7 per cent 
agarose gel electrophoresis and then blotted on a nylon 
membrane. Southern hybridization was performed to 
determine the location of intI1, intI2 and aac(6′)-1b-
cr using the respective probes, under high-stringency 
conditions.
Nucleotide sequence accession numbers: The nucleotide 
sequence data reported here have been assigned the 
following GenBank accession numbers: DQ116793 to 
DQ116794 for gyrA, DQ116795 to DQ116798 for parC 
AB188258 to AB188268; AB188271 to AB188272 for 
resistance gene cassettes, and EF501991 to EF501992 
for acc(6’)-Ib-cr. 
Results
 The antimicrobial susceptibility results showed 
that the ETEC strains were resistant to ampicillin 
(100%), cephalothin, tetracycline, co-trimoxazole, 
nalidixic acid, norfloxacin, ciprofloxacin (94% each), 
chloramphenicol (59%), streptomycin, kanamycin 
(52% each). In addition, most of the ETEC were 
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Table I. List of PCR primer pairs used in this study
Primer
(direction)¶
Locus Primer sequence (5´-3´) Amplicon
(bp)
Reference PCR condition
T† T‡
GA (+)
gyrA
ACGTACTAGGCAATGACTGG
190 18 55 60
GA (-) AGAAGTCGCCGTCGATAGAAC
PC (+)
parC
TGTATGCGATGTCTGAACTG
265 18 55 60
PC (-) CTCAATAGCAGCTCGGAATA
Int1 (+)
intI1
GTTCGGTCAAGGTTCTG
920 This study 50 30
Int1 (-) GCCAACTTTCAGCACATG
Int2 (+)
intI2
ATGTCTAACAGTCCATTTTT
420 This study 50 30
Int2 (-) AAATCTTTAACCCGCAAAC
InF(+)
Gene cassette
GGCATACAAGCAGCAAGC
Variable 19 50 30
InB (-) AAGCAGACTTGACCTGAT
IntI2 (+)
Gene cassette
ACCTTTTTGTCGCATATCCGTG
Variable 20 55 60
Hep51 (-) GATGCCATCGCAAGTACGAG
TEM (+)
blaTEM
CATTTCCGTGTCGCCCTTATTCC
828 21 59 30
TEM (-) GGCACCTATCTCAGCGATCTGTCTA
CAT (+)
catA1
AAGTTGGCAGCATTCACCCG
573 21 61 30
CAT (-) TCGTGGTATTCACTCCAGAGCG
TetA (+)
tetA
GGTCTTGCTCGTCTCGCTGG
690 21 62 30
TetA (-) AACGCCATCCATCCCCGTG
TetB (+)
tetB
CCTTATCATGCCAGTCTTGC
774 22 50 30
TetB (-) ACTGCCGTTTTTTCGCC
TetC (+)
tetC
ACTTGGAGCCACTATCGAC
881 22 50 30
TetC (-) CTACAATCCATGCCAACCC
TetD (+)
tetD
TGGGCAGATGGTCAGATAAG
827 22 50 30
TetD (-) CAGCACACCCTGTAGTTTTC
TetE (+)
tetE
TTAATGGCAACAGCCAGC
853 22 50 30
TetE (-) TCCATACCCATCCATTCCAC
β-Lac (+)
blaCTX-M-3
AATCACTGCGTCAGTTCAC
701 22 50 30
β-Lac (-) TTTATCCCCCACAACCCAG
β-Lac (+) blaSHV TCGCCTGTGTATTATCTCCC 768 22 50 30
β-Lac (-) CGCAGATAAATCACCACAATG
TetY (+)
tetY
ACCGCACTCATTGTTGTC 
823 22 50 30
TetY (-) TTCCAAGCAGCAACACAC 
Aph (+)
aphA1-1a
AACGTCTTGCTCGAGGCCGCG
670 21 65 30
Aph (-) GGCAAGATCCTGGTATCGGTCTGC
AadB (+)
aadB
GGGCGCGTCATGGAGGAGTT
329 21 65 30
AadB (-) TATCGCGACCTGAAAGCGGC
StrA (+)
strA
CCAATCGCAGATAGAAGGCAAG
580 21 65 30
StrA (-) ATCAACTGGCAGGAGGAACAGG
QnrA (+)
qnrA
ATTTCTCACGCCAGGATTTG
516 23, 24 53 45
QnrA (-) GATCGGCAAAGGTTAGGTCA
QnrB (+)
qnrB
GATCGTGAAAGCCAGAAAGG
469 23, 24 53 45
QnrB (-) ACGATGCCTGGTAGTTGTCC
QnrS (+)
qnrS
ACGACATTCGTCAACTGCAA
417 23, 24 53 45
QnrS (-) TAAATTGGCACCCTGTAGGC
Faa(+)
aac(6’)-Ib-cr
GCAACGCAAAAACAAAGTTAGG
561 This study 50 45
Faa(-) GTGTTTGAACCATGTACA
¶+, coding strand; -, noncoding strand; †annealing temperature in °C; ‡extension time in sec
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also resistance to other antibiotics (Table II). The 
multidrug resistant ETEC were not associated with 
a particular serogroup but overall the serogroup 
O1 was comparatively high (53%). The MICs for 
nalidixic acid resistance was high (2000 µg/ml) and 
for fluoroquinolones, the MIC ranged between 250 
and 1000 µg/ml. In six ETEC strains, the MIC for Ct 
and Tz were ranged from >64-340 and >84-168 µg/
ml, respectively (Table III).
 DNA sequencing of the 190-bp PCR product 
covering the QRDR of gyrA demonstrated presence 
of mutations at codons 83 in all the quinolone and 
fluoroquinolone resistant strains compared to the 
sensitive strain AV195 (Table IV). Mutation at codon 
83 was a C→T transversion in the codon TCG that 
resulted substitution of leucine for serine. Except for 
one strain (E17), the second mutation was noted in all 
the strains at position 87 (G→A transversion of codon 
GAC), which resulted in an asparagine substitution 
for an aspartate. A 265-bp PCR amplicon of parC was 
also analyzed in this study. Majority of the quinolone 
resistant strains had a mutation at codon 80 (G→T 
translation of codon AGC), resulting substitution of 
isoleucine for serine. A second mutation at position 84 
(E→G) in the parC was detected in E13 and AV185, 
in which glutamic acid was replaced by glycine. In six 
ETEC strains, mutation was detected at position 108 
(A→V)), where alanine was substituted by valine. 
In three strains (E2, E14, and AV185) the mutation 
at position 108 was absent. Strain AV185 had a third 
mutation at position 90 (A→V), where alanine was 
replaced by valine. Interestingly, the strain AV195 that 
is susceptible for nalidixic acid (MIC 4µg/ml) exhibited 
low-levels of resistance to fluoroquinolones. Since 
none of the fluoroquinolone resistance mechanisms 
were identified in this strain, we assume that it may 
harbour a novel PMQR and/or other hitherto unknown 
functional gene(s). 
 None of the ETEC strains were positive in the Qnr-
PCR assay, indicating the absence of all the tested qnr 
alleles. In addition to the mutations in QRDR, efflux 
pumps play an important role in intrinsic resistance 
of E. coli to fluoroquinolones. The fluoroquinolone 
accumulation kinetics before and after the addition 
of CCCP was almost similar in most of the resistant 
strains (Table IV) indicating the involvement of other 
resistance mechanism(s). Most of the ETEC strains 
(64.7%) harboured the newly described aac(6’)-Ib-cr 
gene, which encodes the fluoroquinolone-modifying 
enzyme aminoglycoside acetyltransferase (Table II). 
In majority of ETEC strains the acc(6’)-Ib-cr gene was 
located in large plasmids of varying sizes and seven 
ETEC strains had this gene in the chromosome (Table 
II). All the six ETEC strains, which were resistant to Ct 
and Tz harboured blaCTX-M-3 (Table III).
 In the colony hybridization assay, class 1 and class 
2 integrons were detected in 35.3 and 17.6 per cent of 
the ETEC strains, respectively. Four strains (23.5%) had 
both the classes of integrons (Table II). ETEC strains 
carrying the integrons were further screened for the 
presence of contiguous resistance gene cassettes, using 
specific primers inF/inB and intl2/Hep51, respectively. 
Of the 10- intI1 probe positive strains, six carried two 
cassettes and the resistance genes detected in these 
strains were dfrA17 and aadA5, which confer resistance 
to trimethoprim and spectinomycin/streptomycin 
using dihydrofolatereductase and adenylytransferase, 
respectively. 
 In addition to these resistance gene cassettes, two 
strains (E9 and E17) gave an additional amplicon with 
a size of 1009 bp, which was identified as aadA1, 
conferring resistance for aminoglycosides. E3 and E6 
strains carried 1009 and about 800 bp with complete 
and incomplete aadA1 gene cassette, respectively. In 
one intI1 probe positive strain (E15), the CS specific 
primers did not gave amplicon. In seven ETEC strains, 
intl2 was detected, of which four were also positive 
for intI1. All the intI2 positive strains carried three 
cassettes (2449 bp) as those found in Tn7, namely 
dfrA1, sat1, and aadA1 (Table II). The sat gene encodes 
for streptothricin acetyltransferase. 
 The plasmid patterns and the location of the 
intI1 gene in the plasmids were not uniform (Table 
II). The restriction enzymes, EcoRI and EcoRV were 
used for digestion of chromosomal DNA, since the 
intI1 did not have the corresponding restriction sites 
for these enzymes. Southern hybridization results 
showed that class 1 integron was detected both in the 
chromosome and large plasmid in most of the strains 
(Table II), however, class 2 integron was detected only 
in the chromosome. In E15, intI1 was detected in the 
large plasmid, however, this strain did not carry any 
resistance gene cassette.
 The alleles of genes such as tet, catA1, strA, blaTEM, 
and aphA1-Ia encoding for resistance for tetracycline, 
chloramphenicol, streptomycin, ampicillin, and 
kanamycin, were detected in 94.1, 70.6, 58.8, 35.2, 
29.4 per cent of the ETEC strains, respectively. An 
analysis on the presence of different resistance gene 
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Table III. MICs of fluroquinolone and ESBLs of ETEC strains
Strain MIC (μg/ml)
Na Cx Nx Ct Tz
E2 2000 250 250 * *
E3 2000 250 250 * *
E4 2000 500 500 * *
E7 2000 1000 1000 * *
E8 ND ND ND >64 >84
E9 2000 1000 500 * *
E13 2000 500 500 >84 >128
E14 2000 1000 500 >102 >168
E15 2000 250 250 * *
E16 2000 250 200 * *
E17 2000 250 250 * *
AV185 2000 1000 500 >250 >112
AV189 ND ND ND >340 >128
AV193 ND ND ND >170 >128
AV195 4 2 2 1.3 <2
Ct, cefotaxime; Tz, ceftazidime; Nx, norfloxacin; ND, not done; 
*susceptible to cefotaxime and ceftazidime
combinations showed that ETEC harbouring blaTEM 
gene was detected with catA1 gene in 5 out of 6 strains 
and the strains harbouring aphA1-Ia were also positive 
for tetAB or tetABE. In one streptomycin resistant strain 
(E2) strA gene was negative but carried aadA5, which 
was associated with the class 1 integron structure. The 
four strains, E2, E8, E10 and E16 were susceptible 
to streptomycin and did not harbour aadA1 or strA. 
In 6 gentamicin resistant strains, aadB, which confer 
gentamicin resistance, was not identified.  
 Among tet gene alleles, tetB was detected in 52.9 
per cent of the ETEC strains. Combination of tetAB 
was detected among four strains, and tetBE, tetABE, 
tetA was detected in one strain each (Table II). The 
other tested tet gene types such as tetC, tetD and tetY 
were not detected in any of the ETEC strains (data 
not shown). When tested for the MIC of tetracycline 
by agar dilution technique with strains harbouring 
different tet gene classes, tetA or tetB alone had the 
MIC of 100 µg/ml. ETEC strains with combination of 
tetBE and tetABE had the MIC of 150 µg/ml (data not 
shown). 
Discussion
 All the ETEC strains isolated from the patients 
with diarrhoea during the outbreak were resistant to 
several antibiotics. The differences found in their XbaI 
PFGE patterns indicate that most of the ETEC strains 
in this study are distinct clones2. The unusual multidrug 
resistance profiles of the ETEC strains prompted 
us to undertake an in depth study on mechanisms of 
antimicrobial resistance using the molecular tools. 
 Fluoroquinolones have been used for the treatment 
of variety of infectious diseases. In the present 
study, most of the ETEC were highly resistant to 
fluoroquinolones. Prior to 1990, resistance of E. coli 
to fluoroquinolones was rare25. As reported with other 
pathogens, use of fluoroquinolones in India may have 
progressively favoured emergence of MDR-ETEC 
strains4-6. Majority of the ETEC investigated in the 
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Table IV. Amino acid substitutions in the QRDRs and fluroquinolone efflux of ETEC strains
Strain Amino acid substitution Accumulation of fluroquinolones [μg/mg (dry weight) of cells]
Cx Nx
GyrA ParC Before addition of 
CCCP
After addition of  
CCCP
Before addition of 
CCCP
After addition of 
CCCP
E2 S83→L, D87→N S80→I, A108 0.064 ± 0.0011 0.089 ± 0.0028 0.161 ± 0.007 0.502 ± 0.0032
E3 S83→L, D87→N S80→I, A108→V 0.067 ± 0.003 0.089 ± 0.0025 0.166 ± 0.003 0.461 ± 0.0021
E4 S83→L, D87→N S80→I, A108→V ND ND ND ND
E7 S83→L, D87→N S80→I, A108→V 0.014 ± 0.0013 0.020 ± 0.0019 0.043 ± 0.0010 0.047 ± 0.0022
E9 S83→L, D87→N S80→I, A108→V ND ND ND ND
E13 S83→L, D87→N S80→I, E84→G 0.009 ± 0.0012 0.020 ± 0.0020 0.024 ± 0.0011 0.044 ± 0.0014
E14 S83→L, D87→N S80→I, A108 0.012 ± 0.0015 0.014 ± 0.0035 0.036 ± 0.0017 0.040 ± 0.0033
E15 S83→L, D87→N S80→I, A108→V ND ND ND ND
E16 S83→L, D87→N S80→I, A108→V ND ND ND ND
E17 S83→L, D87 S80, A108 0.013 ± 0.0011 0.022 ± 0.0021 0.046 ± 0.0014 0.047 ± 0.0024
AV185 S83→L, D87→N S80→I, E84→G, 
A90→V, A108
0.031 ± 0.005 0.090 ± 0.0011 0.133 ± 0.002 0.531 ± 0.0010
AV195 S83, D87 S80, A108 0.088 ± 0.007 0.096 ± 0.009 0.564 ± 0.004 0.590 ± 0.006
ND, not done; Cx, ciprofloxacin; Nx, norfloxcin, CCCP, carbonyl cyanide m-chlorophenylhydrazone. Values are mean, n=3
present study were resistant to several other antibiotics 
as well. It has been demonstrated that fluoroquinolone 
resistance was related with resistance to at least one 
non-fluoroquinolone antibiotic26. In this study, the 
fluoroquinolone resistant ETEC strains had mutations 
in gyrA at positions 83 and 87. The gyrA mutations that 
frequently affect residue serine at 83 and aspartate at 
87 are common among fluoroquinolone resistant E. 
coli27. In addition to the mutations in gyrA, mutations 
were detected in the parC. For the expression of 
high-level resistance, acquisition of a second gyrA 
mutation and a parC mutation seems important. A 
similar resistance mechanism has been observed in E. 
coli strains28. With the sequenced regions of QRDR 
in this study, association could not be made with the 
increased MIC of quinolone/fluoroquinolones and 
amino acid substitutions in topoisomerases. Although 
the quinolone resistance is due to mutations in gyrA 
and parC, studies indicate that resistance can also 
be transferred on plasmids carrying the qnr gene 
alleles7,8.
 Although E. coli has shown to have intrinsic proton-
dependent multidrug-resistant efflux pump systems, 
the specific activity of any one pump in its natural 
state and level has not been established29. CCCP is a 
well-known inhibitor for fluoroquinolone efflux pump 
in many bacteria. After the addition of this proton 
motive force uncoupler, the expected accumulation 
did not occur in most of the fluoroquinolone resistant 
ETEC. In view of the large number of proven or 
putative efflux pumps30, involvement of more than 
one mechanism seems possible. We assume that 
additional non-efflux resistance mechanism(s) may 
also contribute to the high level fluoroquinolone 
resistance.
 Class 1 and class 2 integrons are widely prevalent in 
most of the clinical strains of Gram-negative bacteria. 
Despite the differences in the integrase proteins, the 
two classes of integrons can include identical gene 
cassettes31. Our finding has shown that the dfr and 
aad gene alleles encoding dihydrofolate reductases 
and adenyltransferase, respectively were present in 
both the classes of integrons among ETEC. In this 
study, dfr cassettes (dfrA1 and dfrA17) that confer 
resistance to trimethoprim were detected in majority 
of the ETEC strains. In 50 per cent of the intl1 positive 
ETEC, dfr17 was detected along with aadA5 cassette. 
The dfr and aadA cassettes were shown to be common 
among members of the family Enterobacteriaceae32. 
The dfr was detected behind the 5′-conserved segment, 
which is closest to the promoter, thereby providing 
high-level and conditional resistance. It is likely that 
selection for cassettes carrying dfr genes has occurred 
among ETEC as trimethoprim in combination with 
sulphamethoxazole (co-trimoxazole) is used frequently 
in the treatment of diarrhoea and other infections. 
Presence of aadA5 did not have any influence towards 
resistance of streptomycin, as the aad cassette confers 
resistance only to low level of streptomycin33. One 
ETEC strain (E15), which was intI1 probe positive, 
did not amplify any resistance gene cassette regions, 
possibly due to the variable nature of a 3’-conserved 
segment. 
 In intI2 positive ETEC strains, we have detected 
dfrA1, sat1 and aadA1 gene cassettes conferring 
resistance to trimethoprim, streptothricin, and 
streptomycin/spectinomycin, respectively. Existence 
of sat1 has not been reported in ETEC. Class 2 integron 
carrying dfrA1, sat1 and aadA1 was also reported 
among members of the family Enterobacteriaceae due 
to the defective integrase gene in class 2 integron20. 
 Within the integrons, the genes responsible 
for resistance to beta-lactams, tetracycline, and 
chloramphenicol were not mapped in this study. 
The tetB gene that encodes an efflux protein, which 
confers resistance to tetracycline, was predominant in 
majority of our ETEC strains. As reported in other 
findings, combination of tet genes was detected in 
six ETEC strains22. Except for one strain (AV189), 
tetA was always detected with tetB in this study. 
Interestingly, ETEC harbouring combination of tetA, 
tetB or tetA, tetB, and tetE expressed high MIC for 
tetracycline than tetB alone or tetB and tetE. None 
of the six gentamicin resistant strains carried the 
aadB gene. Possibly, the other variant genes encoding 
aminoglycoside adenyltransferase may play a role in 
resistance towards gentamicin. We have tested the 
ETEC strains for ESBL genes such as blaSHV and blaCTX-
M-3genes for blaTEM, which were widely distributed 
in ETEC22. Due to co-selection, blaTEM was found 
in association with the catA1 in most of the ETEC 
strains22. Similarly, aphA1-Ia was detected along with 
different tet alleles other than tetB. We have detected 
the aminoglycosides (neomycin and kanamycin) 
resistance gene (aphA1-Ia) in five strains (29.4%), 
even though 59 per cent of the ETEC were resistant 
to kanamycin. This may be due to cross-resistance 
caused by aminoglycoside resistance genes. In this 
study, 64.7 per cent of the ETEC strains harboured 
aac(6’)-Ib-cr, of which, 73 per cent of the strains 
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concomitantly had ESBL genes. The synergistic 
effect of these genes on increased resistance toward 
fluoroquinolones has been established in many 
members of Enterobacteriaceae34. 
 Even though the antimicrobial therapy is 
generally supportive for the treatment of ETEC 
mediated diarrhoea, its rational use is difficult to 
implement in diarrhoea endemic countries especially 
during outbreaks. As evidenced from this study, 
innate gene mutations and acquisition of multidrug 
resistance genes through mobile genetic elements 
might have contributed to the emergence of MDR-
ETEC. This study reinforces the necessity of utilizing 
molecular techniques in the epidemiological studies 
to understand the nature of resistance responsible 
for antimicrobial resistance in different species of 
pathogenic bacteria.
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